Loading…

Epileptic and nonepileptic features in patients with early onset epileptic encephalopathy and STXBP1 mutations

Summary Purpose:  STXBP1 (MUNC18‐1) mutations have been associated with various types of epilepsies, mostly beginning early in life. To refine the phenotype associated with STXBP1 aberrations in early onset epileptic syndromes, we studied this gene in a cohort of patients with early onset epileptic...

Full description

Saved in:
Bibliographic Details
Published in:Epilepsia (Copenhagen) 2011-10, Vol.52 (10), p.1828-1834
Main Authors: Milh, Mathieu, Villeneuve, Nathalie, Chouchane, Mondher, Kaminska, Anna, Laroche, Cécile, Barthez, Marie Anne, Gitiaux, Cyril, Bartoli, Céline, Borges‐Correia, Ana, Cacciagli, Pierre, Mignon‐Ravix, Cécile, Cuberos, Hélène, Chabrol, Brigitte, Villard, Laurent
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4631-68a75bdfd80518bbd00e939e88a049a74f73baf41c8c9df88b9962d339b94bd13
cites
container_end_page 1834
container_issue 10
container_start_page 1828
container_title Epilepsia (Copenhagen)
container_volume 52
creator Milh, Mathieu
Villeneuve, Nathalie
Chouchane, Mondher
Kaminska, Anna
Laroche, Cécile
Barthez, Marie Anne
Gitiaux, Cyril
Bartoli, Céline
Borges‐Correia, Ana
Cacciagli, Pierre
Mignon‐Ravix, Cécile
Cuberos, Hélène
Chabrol, Brigitte
Villard, Laurent
description Summary Purpose:  STXBP1 (MUNC18‐1) mutations have been associated with various types of epilepsies, mostly beginning early in life. To refine the phenotype associated with STXBP1 aberrations in early onset epileptic syndromes, we studied this gene in a cohort of patients with early onset epileptic encephalopathy. Methods:  STXBP1 was screened in a multicenter cohort of 52 patients with early onset epilepsy (first seizure observed before the age of 3 months), no cortical malformation on brain magnetic resonance imaging (MRI), and negative metabolic screening. Three groups of patients could be distinguished in this cohort: (1) Ohtahara syndromes (n = 38); (2) early myoclonic encephalopathies (n = 7); and (3) early onset epileptic encephalopathies that did not match any familiar syndrome (n = 7). None of the patients displayed any cortical malformation on brain MRI and all were screened through multiple video–electroencephalography (EEG) recordings for a time period spanning from birth to their sixth postnatal month. Subsequently, patients had standard EEG or video‐EEG recordings. Key Findings:  We found five novel STXBP1 mutations in patients for whom video‐EEG recordings could be sampled from the beginning of the disease. All patients with a mutation displayed Ohtahara syndrome, since most early seizures could be classified as epileptic spasms and since the silent EEG periods were on average shorter than bursts. However, each patient in addition displayed a particular clinical and EEG feature: In two patients, early seizures were clonic, with very early EEG studies exhibiting relatively low amplitude bursts of activity before progressing into a typical suppression‐burst pattern, whereas the three other patients displayed epileptic spasms associated with typical suppression‐burst patterns starting from the early recordings. Epilepsy dramatically improved after 6 months and finally disappeared before the end of the first year of life for four patients; the remaining one patient had few seizures until 18 months of age. In parallel, EEG paroxysmal abnormalities disappeared in three patients and decreased in two, giving place to continuous activity with fast rhythms. Each patient displayed frequent nonepileptic movement disorders that could easily be mistaken for epileptic seizures. These movements could be observed as early as the neonatal period and, unlike seizures, persisted during all the follow‐up period. Significance:  We confirm that STXBP1 is a major g
doi_str_mv 10.1111/j.1528-1167.2011.03181.x
format article
fullrecord <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_01668681v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3278081061</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4631-68a75bdfd80518bbd00e939e88a049a74f73baf41c8c9df88b9962d339b94bd13</originalsourceid><addsrcrecordid>eNqFkk1r3DAQhkVJaTZJ_0IQ5BB6sDtj2fo49JAs2ySw0IUm0JuQbZn14pVdy26y_75ydrOBXqqLxMyjl5l5hxCKEGM4XzcxZomMELmIE0CMgaHE-OUDmR0TJ2QGgCxSmYRTcub9BgAEF-wTOU1QCFBJOiNu0dWN7Ya6oMaV1LXOHgOVNcPYW09rRzsz1NYNnj7Xw5pa0zc72jpvB_rOW1fYbm2aNsDr3avez8dftyuk23EI_wN_QT5WpvH28-E-J0_fF4_z-2j54-5hfrOMipQzjLg0IsvLqpSQoczzEsAqpqyUBlJlRFoJlpsqxUIWqqykzJXiScmYylWal8jOyZe9bihHd329Nf1Ot6bW9zdLPcUAOZdc4p-Jvd6zXd_-Hq0f9Lb2hW0a42w7eq3CxDNMk-z_JCQSJDIZyKt_yE079i60rIOWSJjgMFGXB2rMt7Y8FvpmTwC-7YHnMOPdMY-gpzXQGz25rSe39bQG-nUN9IterB6mF_sLakuk2w</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1517237608</pqid></control><display><type>article</type><title>Epileptic and nonepileptic features in patients with early onset epileptic encephalopathy and STXBP1 mutations</title><source>Wiley</source><creator>Milh, Mathieu ; Villeneuve, Nathalie ; Chouchane, Mondher ; Kaminska, Anna ; Laroche, Cécile ; Barthez, Marie Anne ; Gitiaux, Cyril ; Bartoli, Céline ; Borges‐Correia, Ana ; Cacciagli, Pierre ; Mignon‐Ravix, Cécile ; Cuberos, Hélène ; Chabrol, Brigitte ; Villard, Laurent</creator><creatorcontrib>Milh, Mathieu ; Villeneuve, Nathalie ; Chouchane, Mondher ; Kaminska, Anna ; Laroche, Cécile ; Barthez, Marie Anne ; Gitiaux, Cyril ; Bartoli, Céline ; Borges‐Correia, Ana ; Cacciagli, Pierre ; Mignon‐Ravix, Cécile ; Cuberos, Hélène ; Chabrol, Brigitte ; Villard, Laurent</creatorcontrib><description>Summary Purpose:  STXBP1 (MUNC18‐1) mutations have been associated with various types of epilepsies, mostly beginning early in life. To refine the phenotype associated with STXBP1 aberrations in early onset epileptic syndromes, we studied this gene in a cohort of patients with early onset epileptic encephalopathy. Methods:  STXBP1 was screened in a multicenter cohort of 52 patients with early onset epilepsy (first seizure observed before the age of 3 months), no cortical malformation on brain magnetic resonance imaging (MRI), and negative metabolic screening. Three groups of patients could be distinguished in this cohort: (1) Ohtahara syndromes (n = 38); (2) early myoclonic encephalopathies (n = 7); and (3) early onset epileptic encephalopathies that did not match any familiar syndrome (n = 7). None of the patients displayed any cortical malformation on brain MRI and all were screened through multiple video–electroencephalography (EEG) recordings for a time period spanning from birth to their sixth postnatal month. Subsequently, patients had standard EEG or video‐EEG recordings. Key Findings:  We found five novel STXBP1 mutations in patients for whom video‐EEG recordings could be sampled from the beginning of the disease. All patients with a mutation displayed Ohtahara syndrome, since most early seizures could be classified as epileptic spasms and since the silent EEG periods were on average shorter than bursts. However, each patient in addition displayed a particular clinical and EEG feature: In two patients, early seizures were clonic, with very early EEG studies exhibiting relatively low amplitude bursts of activity before progressing into a typical suppression‐burst pattern, whereas the three other patients displayed epileptic spasms associated with typical suppression‐burst patterns starting from the early recordings. Epilepsy dramatically improved after 6 months and finally disappeared before the end of the first year of life for four patients; the remaining one patient had few seizures until 18 months of age. In parallel, EEG paroxysmal abnormalities disappeared in three patients and decreased in two, giving place to continuous activity with fast rhythms. Each patient displayed frequent nonepileptic movement disorders that could easily be mistaken for epileptic seizures. These movements could be observed as early as the neonatal period and, unlike seizures, persisted during all the follow‐up period. Significance:  We confirm that STXBP1 is a major gene to screen in cases of Ohtahara syndrome, since it is mutated in &gt;10% of the Ohtahara patients within our cohort. This gene should particularly be tested in the case of a surprising evolution of the patient condition if epileptic seizures and EEG paroxysmal activity disappear and are replaced by fast rhythms after the end of the first postnatal year.</description><identifier>ISSN: 0013-9580</identifier><identifier>EISSN: 1528-1167</identifier><identifier>EISSN: 1528-1157</identifier><identifier>DOI: 10.1111/j.1528-1167.2011.03181.x</identifier><identifier>PMID: 21770924</identifier><identifier>CODEN: EPILAK</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Age ; Age of Onset ; Anticonvulsants - therapeutic use ; Birth ; Brain ; Brain - pathology ; Brain - physiopathology ; Cortex ; EEG ; Electroencephalography ; Encephalopathy ; Encephalopathy Ohtahara ; Epilepsy ; Epilepsy - drug therapy ; Epilepsy - genetics ; Epilepsy - pathology ; Epilepsy - physiopathology ; Evolution ; Evolutionary genetics ; Genetic ; Genetics ; Genotype ; Human health and pathology ; Humans ; Infant ; Infant, Newborn ; Life Sciences ; Magnetic Resonance Imaging ; Movement disorders ; Munc18 Proteins - genetics ; Mutation ; Neonates ; Neuroimaging ; Neurons and Cognition ; NMR ; Nuclear magnetic resonance ; Oligonucleotide Array Sequence Analysis ; Rhythms ; Seizures ; Suppression‐burst ; Syndrome</subject><ispartof>Epilepsia (Copenhagen), 2011-10, Vol.52 (10), p.1828-1834</ispartof><rights>Wiley Periodicals, Inc. © 2011 International League Against Epilepsy</rights><rights>Wiley Periodicals, Inc. © 2011 International League Against Epilepsy.</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4631-68a75bdfd80518bbd00e939e88a049a74f73baf41c8c9df88b9962d339b94bd13</citedby><orcidid>0000-0002-2190-6843 ; 0000-0001-6657-5008</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21770924$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://amu.hal.science/hal-01668681$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Milh, Mathieu</creatorcontrib><creatorcontrib>Villeneuve, Nathalie</creatorcontrib><creatorcontrib>Chouchane, Mondher</creatorcontrib><creatorcontrib>Kaminska, Anna</creatorcontrib><creatorcontrib>Laroche, Cécile</creatorcontrib><creatorcontrib>Barthez, Marie Anne</creatorcontrib><creatorcontrib>Gitiaux, Cyril</creatorcontrib><creatorcontrib>Bartoli, Céline</creatorcontrib><creatorcontrib>Borges‐Correia, Ana</creatorcontrib><creatorcontrib>Cacciagli, Pierre</creatorcontrib><creatorcontrib>Mignon‐Ravix, Cécile</creatorcontrib><creatorcontrib>Cuberos, Hélène</creatorcontrib><creatorcontrib>Chabrol, Brigitte</creatorcontrib><creatorcontrib>Villard, Laurent</creatorcontrib><title>Epileptic and nonepileptic features in patients with early onset epileptic encephalopathy and STXBP1 mutations</title><title>Epilepsia (Copenhagen)</title><addtitle>Epilepsia</addtitle><description>Summary Purpose:  STXBP1 (MUNC18‐1) mutations have been associated with various types of epilepsies, mostly beginning early in life. To refine the phenotype associated with STXBP1 aberrations in early onset epileptic syndromes, we studied this gene in a cohort of patients with early onset epileptic encephalopathy. Methods:  STXBP1 was screened in a multicenter cohort of 52 patients with early onset epilepsy (first seizure observed before the age of 3 months), no cortical malformation on brain magnetic resonance imaging (MRI), and negative metabolic screening. Three groups of patients could be distinguished in this cohort: (1) Ohtahara syndromes (n = 38); (2) early myoclonic encephalopathies (n = 7); and (3) early onset epileptic encephalopathies that did not match any familiar syndrome (n = 7). None of the patients displayed any cortical malformation on brain MRI and all were screened through multiple video–electroencephalography (EEG) recordings for a time period spanning from birth to their sixth postnatal month. Subsequently, patients had standard EEG or video‐EEG recordings. Key Findings:  We found five novel STXBP1 mutations in patients for whom video‐EEG recordings could be sampled from the beginning of the disease. All patients with a mutation displayed Ohtahara syndrome, since most early seizures could be classified as epileptic spasms and since the silent EEG periods were on average shorter than bursts. However, each patient in addition displayed a particular clinical and EEG feature: In two patients, early seizures were clonic, with very early EEG studies exhibiting relatively low amplitude bursts of activity before progressing into a typical suppression‐burst pattern, whereas the three other patients displayed epileptic spasms associated with typical suppression‐burst patterns starting from the early recordings. Epilepsy dramatically improved after 6 months and finally disappeared before the end of the first year of life for four patients; the remaining one patient had few seizures until 18 months of age. In parallel, EEG paroxysmal abnormalities disappeared in three patients and decreased in two, giving place to continuous activity with fast rhythms. Each patient displayed frequent nonepileptic movement disorders that could easily be mistaken for epileptic seizures. These movements could be observed as early as the neonatal period and, unlike seizures, persisted during all the follow‐up period. Significance:  We confirm that STXBP1 is a major gene to screen in cases of Ohtahara syndrome, since it is mutated in &gt;10% of the Ohtahara patients within our cohort. This gene should particularly be tested in the case of a surprising evolution of the patient condition if epileptic seizures and EEG paroxysmal activity disappear and are replaced by fast rhythms after the end of the first postnatal year.</description><subject>Age</subject><subject>Age of Onset</subject><subject>Anticonvulsants - therapeutic use</subject><subject>Birth</subject><subject>Brain</subject><subject>Brain - pathology</subject><subject>Brain - physiopathology</subject><subject>Cortex</subject><subject>EEG</subject><subject>Electroencephalography</subject><subject>Encephalopathy</subject><subject>Encephalopathy Ohtahara</subject><subject>Epilepsy</subject><subject>Epilepsy - drug therapy</subject><subject>Epilepsy - genetics</subject><subject>Epilepsy - pathology</subject><subject>Epilepsy - physiopathology</subject><subject>Evolution</subject><subject>Evolutionary genetics</subject><subject>Genetic</subject><subject>Genetics</subject><subject>Genotype</subject><subject>Human health and pathology</subject><subject>Humans</subject><subject>Infant</subject><subject>Infant, Newborn</subject><subject>Life Sciences</subject><subject>Magnetic Resonance Imaging</subject><subject>Movement disorders</subject><subject>Munc18 Proteins - genetics</subject><subject>Mutation</subject><subject>Neonates</subject><subject>Neuroimaging</subject><subject>Neurons and Cognition</subject><subject>NMR</subject><subject>Nuclear magnetic resonance</subject><subject>Oligonucleotide Array Sequence Analysis</subject><subject>Rhythms</subject><subject>Seizures</subject><subject>Suppression‐burst</subject><subject>Syndrome</subject><issn>0013-9580</issn><issn>1528-1167</issn><issn>1528-1157</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><recordid>eNqFkk1r3DAQhkVJaTZJ_0IQ5BB6sDtj2fo49JAs2ySw0IUm0JuQbZn14pVdy26y_75ydrOBXqqLxMyjl5l5hxCKEGM4XzcxZomMELmIE0CMgaHE-OUDmR0TJ2QGgCxSmYRTcub9BgAEF-wTOU1QCFBJOiNu0dWN7Ya6oMaV1LXOHgOVNcPYW09rRzsz1NYNnj7Xw5pa0zc72jpvB_rOW1fYbm2aNsDr3avez8dftyuk23EI_wN_QT5WpvH28-E-J0_fF4_z-2j54-5hfrOMipQzjLg0IsvLqpSQoczzEsAqpqyUBlJlRFoJlpsqxUIWqqykzJXiScmYylWal8jOyZe9bihHd329Nf1Ot6bW9zdLPcUAOZdc4p-Jvd6zXd_-Hq0f9Lb2hW0a42w7eq3CxDNMk-z_JCQSJDIZyKt_yE079i60rIOWSJjgMFGXB2rMt7Y8FvpmTwC-7YHnMOPdMY-gpzXQGz25rSe39bQG-nUN9IterB6mF_sLakuk2w</recordid><startdate>201110</startdate><enddate>201110</enddate><creator>Milh, Mathieu</creator><creator>Villeneuve, Nathalie</creator><creator>Chouchane, Mondher</creator><creator>Kaminska, Anna</creator><creator>Laroche, Cécile</creator><creator>Barthez, Marie Anne</creator><creator>Gitiaux, Cyril</creator><creator>Bartoli, Céline</creator><creator>Borges‐Correia, Ana</creator><creator>Cacciagli, Pierre</creator><creator>Mignon‐Ravix, Cécile</creator><creator>Cuberos, Hélène</creator><creator>Chabrol, Brigitte</creator><creator>Villard, Laurent</creator><general>Blackwell Publishing Ltd</general><general>Wiley Subscription Services, Inc</general><general>Wiley</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7TK</scope><scope>7X8</scope><scope>1XC</scope><orcidid>https://orcid.org/0000-0002-2190-6843</orcidid><orcidid>https://orcid.org/0000-0001-6657-5008</orcidid></search><sort><creationdate>201110</creationdate><title>Epileptic and nonepileptic features in patients with early onset epileptic encephalopathy and STXBP1 mutations</title><author>Milh, Mathieu ; Villeneuve, Nathalie ; Chouchane, Mondher ; Kaminska, Anna ; Laroche, Cécile ; Barthez, Marie Anne ; Gitiaux, Cyril ; Bartoli, Céline ; Borges‐Correia, Ana ; Cacciagli, Pierre ; Mignon‐Ravix, Cécile ; Cuberos, Hélène ; Chabrol, Brigitte ; Villard, Laurent</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4631-68a75bdfd80518bbd00e939e88a049a74f73baf41c8c9df88b9962d339b94bd13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Age</topic><topic>Age of Onset</topic><topic>Anticonvulsants - therapeutic use</topic><topic>Birth</topic><topic>Brain</topic><topic>Brain - pathology</topic><topic>Brain - physiopathology</topic><topic>Cortex</topic><topic>EEG</topic><topic>Electroencephalography</topic><topic>Encephalopathy</topic><topic>Encephalopathy Ohtahara</topic><topic>Epilepsy</topic><topic>Epilepsy - drug therapy</topic><topic>Epilepsy - genetics</topic><topic>Epilepsy - pathology</topic><topic>Epilepsy - physiopathology</topic><topic>Evolution</topic><topic>Evolutionary genetics</topic><topic>Genetic</topic><topic>Genetics</topic><topic>Genotype</topic><topic>Human health and pathology</topic><topic>Humans</topic><topic>Infant</topic><topic>Infant, Newborn</topic><topic>Life Sciences</topic><topic>Magnetic Resonance Imaging</topic><topic>Movement disorders</topic><topic>Munc18 Proteins - genetics</topic><topic>Mutation</topic><topic>Neonates</topic><topic>Neuroimaging</topic><topic>Neurons and Cognition</topic><topic>NMR</topic><topic>Nuclear magnetic resonance</topic><topic>Oligonucleotide Array Sequence Analysis</topic><topic>Rhythms</topic><topic>Seizures</topic><topic>Suppression‐burst</topic><topic>Syndrome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Milh, Mathieu</creatorcontrib><creatorcontrib>Villeneuve, Nathalie</creatorcontrib><creatorcontrib>Chouchane, Mondher</creatorcontrib><creatorcontrib>Kaminska, Anna</creatorcontrib><creatorcontrib>Laroche, Cécile</creatorcontrib><creatorcontrib>Barthez, Marie Anne</creatorcontrib><creatorcontrib>Gitiaux, Cyril</creatorcontrib><creatorcontrib>Bartoli, Céline</creatorcontrib><creatorcontrib>Borges‐Correia, Ana</creatorcontrib><creatorcontrib>Cacciagli, Pierre</creatorcontrib><creatorcontrib>Mignon‐Ravix, Cécile</creatorcontrib><creatorcontrib>Cuberos, Hélène</creatorcontrib><creatorcontrib>Chabrol, Brigitte</creatorcontrib><creatorcontrib>Villard, Laurent</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><jtitle>Epilepsia (Copenhagen)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Milh, Mathieu</au><au>Villeneuve, Nathalie</au><au>Chouchane, Mondher</au><au>Kaminska, Anna</au><au>Laroche, Cécile</au><au>Barthez, Marie Anne</au><au>Gitiaux, Cyril</au><au>Bartoli, Céline</au><au>Borges‐Correia, Ana</au><au>Cacciagli, Pierre</au><au>Mignon‐Ravix, Cécile</au><au>Cuberos, Hélène</au><au>Chabrol, Brigitte</au><au>Villard, Laurent</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Epileptic and nonepileptic features in patients with early onset epileptic encephalopathy and STXBP1 mutations</atitle><jtitle>Epilepsia (Copenhagen)</jtitle><addtitle>Epilepsia</addtitle><date>2011-10</date><risdate>2011</risdate><volume>52</volume><issue>10</issue><spage>1828</spage><epage>1834</epage><pages>1828-1834</pages><issn>0013-9580</issn><eissn>1528-1167</eissn><eissn>1528-1157</eissn><coden>EPILAK</coden><abstract>Summary Purpose:  STXBP1 (MUNC18‐1) mutations have been associated with various types of epilepsies, mostly beginning early in life. To refine the phenotype associated with STXBP1 aberrations in early onset epileptic syndromes, we studied this gene in a cohort of patients with early onset epileptic encephalopathy. Methods:  STXBP1 was screened in a multicenter cohort of 52 patients with early onset epilepsy (first seizure observed before the age of 3 months), no cortical malformation on brain magnetic resonance imaging (MRI), and negative metabolic screening. Three groups of patients could be distinguished in this cohort: (1) Ohtahara syndromes (n = 38); (2) early myoclonic encephalopathies (n = 7); and (3) early onset epileptic encephalopathies that did not match any familiar syndrome (n = 7). None of the patients displayed any cortical malformation on brain MRI and all were screened through multiple video–electroencephalography (EEG) recordings for a time period spanning from birth to their sixth postnatal month. Subsequently, patients had standard EEG or video‐EEG recordings. Key Findings:  We found five novel STXBP1 mutations in patients for whom video‐EEG recordings could be sampled from the beginning of the disease. All patients with a mutation displayed Ohtahara syndrome, since most early seizures could be classified as epileptic spasms and since the silent EEG periods were on average shorter than bursts. However, each patient in addition displayed a particular clinical and EEG feature: In two patients, early seizures were clonic, with very early EEG studies exhibiting relatively low amplitude bursts of activity before progressing into a typical suppression‐burst pattern, whereas the three other patients displayed epileptic spasms associated with typical suppression‐burst patterns starting from the early recordings. Epilepsy dramatically improved after 6 months and finally disappeared before the end of the first year of life for four patients; the remaining one patient had few seizures until 18 months of age. In parallel, EEG paroxysmal abnormalities disappeared in three patients and decreased in two, giving place to continuous activity with fast rhythms. Each patient displayed frequent nonepileptic movement disorders that could easily be mistaken for epileptic seizures. These movements could be observed as early as the neonatal period and, unlike seizures, persisted during all the follow‐up period. Significance:  We confirm that STXBP1 is a major gene to screen in cases of Ohtahara syndrome, since it is mutated in &gt;10% of the Ohtahara patients within our cohort. This gene should particularly be tested in the case of a surprising evolution of the patient condition if epileptic seizures and EEG paroxysmal activity disappear and are replaced by fast rhythms after the end of the first postnatal year.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>21770924</pmid><doi>10.1111/j.1528-1167.2011.03181.x</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0002-2190-6843</orcidid><orcidid>https://orcid.org/0000-0001-6657-5008</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0013-9580
ispartof Epilepsia (Copenhagen), 2011-10, Vol.52 (10), p.1828-1834
issn 0013-9580
1528-1167
1528-1157
language eng
recordid cdi_hal_primary_oai_HAL_hal_01668681v1
source Wiley
subjects Age
Age of Onset
Anticonvulsants - therapeutic use
Birth
Brain
Brain - pathology
Brain - physiopathology
Cortex
EEG
Electroencephalography
Encephalopathy
Encephalopathy Ohtahara
Epilepsy
Epilepsy - drug therapy
Epilepsy - genetics
Epilepsy - pathology
Epilepsy - physiopathology
Evolution
Evolutionary genetics
Genetic
Genetics
Genotype
Human health and pathology
Humans
Infant
Infant, Newborn
Life Sciences
Magnetic Resonance Imaging
Movement disorders
Munc18 Proteins - genetics
Mutation
Neonates
Neuroimaging
Neurons and Cognition
NMR
Nuclear magnetic resonance
Oligonucleotide Array Sequence Analysis
Rhythms
Seizures
Suppression‐burst
Syndrome
title Epileptic and nonepileptic features in patients with early onset epileptic encephalopathy and STXBP1 mutations
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T19%3A55%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Epileptic%20and%20nonepileptic%20features%20in%20patients%20with%20early%20onset%20epileptic%20encephalopathy%20and%20STXBP1%20mutations&rft.jtitle=Epilepsia%20(Copenhagen)&rft.au=Milh,%20Mathieu&rft.date=2011-10&rft.volume=52&rft.issue=10&rft.spage=1828&rft.epage=1834&rft.pages=1828-1834&rft.issn=0013-9580&rft.eissn=1528-1167&rft.coden=EPILAK&rft_id=info:doi/10.1111/j.1528-1167.2011.03181.x&rft_dat=%3Cproquest_hal_p%3E3278081061%3C/proquest_hal_p%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4631-68a75bdfd80518bbd00e939e88a049a74f73baf41c8c9df88b9962d339b94bd13%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1517237608&rft_id=info:pmid/21770924&rfr_iscdi=true